Evaluation of the safety of using propofol for paediatric procedural sedation: A systematic review and meta-analysis

Area of Science:

• Anesthesiology
• Pediatric Sedation
• Evidence-Based Medicine

Background:

• Propofol is a common choice for pediatric procedural sedation.
• Concerns exist regarding potential respiratory and cardiac complications.
• Off-label use is prevalent in many countries despite available trials.

Purpose of the Study:

• To systematically review and meta-analyze randomized controlled trials (RCTs) comparing propofol with other agents for pediatric procedural sedation.
• To provide evidence for regulatory and reimbursement policy considerations.
• To assess the safety and efficacy of propofol in pediatric patients.

Main Methods:

• Systematic literature search of MEDLINE, Embase, and Cochrane Central Register of Controlled Trials up to January 31, 2018.
• Meta-analysis of 30 identified RCTs.
• Comparison of propofol with alternative sedative agents or opioids.

Main Results:

• Propofol sedation demonstrated advantages in recovery time compared to other drugs.
• No excessive cardiovascular or respiratory adverse events were noted with propofol.
• Safety profiles for coughing, nausea, vomiting, and emergence delirium were similar to other agents.

Conclusions:

• The evidence supports propofol as a favorable option for pediatric procedural sedation.
• Regulatory bodies and policymakers should consider propofol more positively.
• Further evaluation may inform reimbursement policies for propofol in pediatric care.